Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Abdullah, E. Vollmer, P. Zabel, N. Reiling, C. Vock, T. Goldmann (Borstel, Germany). Pulmonary haptoglobin (pHp) is a scavenger system preventing arterial leakages. Eur Respir J 2012; 40: Suppl. 56, 3727

Member's Comments

No comment yet.

Related content which might interest you: Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Elevated pulmonary capillary pressure in pulmonary arterial hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 3s Year: 2001 Serum and pulmonary uric acid in pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020 Year: 2021 Measurement of gas transfer components using nitric oxide in post pulmonary endartectomy (PEA) chronic thromboembolic hypertension (CTEPH) patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Expression of the serotonin 1b receptor in experimental pulmonary hypertension Source: Eur Respir J 2003; 22: 408-412 Year: 2003 Hepatopulmonary syndrome: a liver-induced oxygenation defect Source: Eur Respir Mon 2011; 54: 246-264 Year: 2011 Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Roundabout (Robo) receptors on pulmonary artery endothelial cells: Implications for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Pulmonary functions and arterial blood gases in portal hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001 Platelets and pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Reduced pulmonary capillary volume (Vc) is responsable for the increased alveolar exhaled nitric oxide (CANO) in patients with progressive systemic sclerosis (PSS) and pulmonary hypertension (PH) Source: Eur Respir J 2005; 26: Suppl. 49, 561s Year: 2005 Pathophysiology of pulmonary arterial hypertension Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=191 Year: 2004 Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? Source: Eur Respir J 2016; 48: 1265-1267 Year: 2016 Changes in red blood cell membrane structure in pulmonary arterial hypertension Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 PKCalpha deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 via increased TXA2 receptor expression Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Acetylene single breath estimation of effective pulmonary blood flow in patients with pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 423s Year: 2006 Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014